Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Korea reinforces biopharma leadership at Global Bio Conference 2025 2025-09-15 20:30
Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma 2025-09-15 12:11
Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc 2025-09-15 12:06
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations 2025-09-15 08:00
Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101 2025-09-15 08:00
Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium 2025-09-15 07:45
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq 2025-09-12 20:00
The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration 2025-09-12 09:51
Zhimeng Biopharma's Investigational Drug Approved to Initiate Phase 2 Epilepsy Clinical Trial in China 2025-09-12 00:00
Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine 2025-09-11 14:56
Fosun International Recognized among Fortune's 2025 "Most Admired Chinese Companies" List 2025-09-11 09:00
C-Ray Therapeutics Supports Mednovo's Phase III Clinical Trial with First Patient Dosed for Lutetium [177Lu] Oxodotreotide Injection 2025-09-10 21:30
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee 2025-09-10 20:10
ImmVira Announces First-in-Human Data of Engineered Exosome MVR-EX105 for Fat Reduction and Muscle Preservation by Topical Application at 2025 Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders 2025-09-10 10:49
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis 2025-09-10 07:01
iRegene Therapeutics Secures Series B+ Financing Following FDA Fast Track Designation for its Flagship Product NouvNeu001 2025-09-09 21:00
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals 2025-09-09 20:42
Dizal Showcases Robust Portfolio of Lung Cancer Studies at 2025 WCLC 2025-09-09 18:00
WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry 2025-09-09 18:00
Nobel Laureate Headlines Global Discussion in Cell & Gene Therapy in London 2025-09-08 20:49
1 18 19 20 21 22 482